CMS Takes Another Step Toward Collecting Hospitals’ 340B Acquisition Costs
The Centers for Medicare & Medicaid Services (CMS) has taken another step toward requiring hospitals to let it see their 340B drug acquisition costs so CMS can base the hospitals’ Medicare Part B drug reimbursement on those costs.
The latest development came yesterday in a notice CMS posted for public inspection prior to publication in the Federal Register tomorrow. It says CMS is seeking White House Office of Management and Budget approval under the federal Paperwork Reduction Act for the forms necessary to collect hospitals’ 340B drug acquisition costs. Comments on the new notice are expected to be due on March 9.
CMS Takes Another Step Toward Collecting Hospitals’ 340B Acquisition Costs The Centers for Medicare & Medicaid Services (CMS) has taken another step toward requiring hospitals to let it see their 340B drug acquisition costs so CMS can base the hospitals’ […]
Please Login or Become a Paid Subscriber to View this Content
If you are already a paid subscriber, please follow the steps below.
